Overview

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

Status:
Completed

Trial end date:
2019-06-19

Target enrollment:

Participant gender:

Summary

This will be an open-label study designed to assess the safety and plasma PK of topically applied IDP-126 Gel compared to Control Gel.

Phase:

Phase 1

Details

Lead Sponsor:

Bausch Health Americas, Inc.